|
|
Volumn 352, Issue 9, 2005, Pages 933-934
|
|
Toward a new therapy for tuberculosis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 (6 BROMO 2 METHOXY 3 QUINOLINYL) 4 DIMETHYLAMINO 2 (1 NAPHTHYL) 1 PHENYL 2 BUTANOL;
ANTIBIOTIC AGENT;
ETHAMBUTOL;
ISONIAZID;
MEFLOQUINE;
PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;
PYRAZINAMIDE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIFAMPICIN;
UNCLASSIFIED DRUG;
1 (6 BROMO 2 METHOXY QUINOLIN 3 YL) 4 DIMETHYLAMINO 2 (3 FLUOROPHENYL) 1 PHENYL BUTAN 2 OL;
1-(6-BROMO-2-METHOXY-QUINOLIN-3-YL)-4-DIMETHYLAMINO-2-(3-FLUOROPHENYL)-1-PHENYL-BUTAN-2-OL;
QUINOLINE DERIVATIVE;
TUBERCULOSTATIC AGENT;
ARTICLE;
CELL MEMBRANE PERMEABILITY;
CHEMICAL MODIFICATION;
DRUG EFFECT;
DRUG IDENTIFICATION;
DRUG SCREENING;
DRUG SENSITIVITY;
DRUG TARGETING;
DRUG TOLERANCE;
ENZYME SYNTHESIS;
GENE MUTATION;
GROWTH INHIBITION;
HUMAN;
MICROBIAL ACTIVITY;
MICROBIAL GROWTH;
MYCOBACTERIUM SMEGMATIS;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
PRIORITY JOURNAL;
TREATMENT FAILURE;
TUBERCULOSIS;
ANIMAL;
ANTIBIOTIC RESISTANCE;
GENETICS;
MOUSE;
MUTATION;
ANIMALS;
ANTIBIOTICS, ANTITUBERCULAR;
DRUG RESISTANCE, BACTERIAL;
HUMANS;
MICE;
MUTATION;
MYCOBACTERIUM SMEGMATIS;
MYCOBACTERIUM TUBERCULOSIS;
QUINOLINES;
TUBERCULOSIS;
|
|
EID: 14544274534
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMcibr044438 Document Type: Article |
|
Times cited : (12)
|
|
References (1)
|
